Literature DB >> 9888875

Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries.

Y X Chen1, Y Nakashima, K Tanaka, S Shiraishi, K Nakagawa, K Sueishi.   

Abstract

Neovascularization is well known to occur in human atherosclerotic plaques; however, its pathophysiological roles, mechanisms, and stimuli in atherogenesis still remain unclear. In this study, 525 tissue blocks of coronary artery tissue obtained at autopsy from 48 patients ranging in age from 20 to 93 years old (mean+/-SD, 71+/-15 years) were immunohistochemically examined for vascular endothelial growth factor (VEGF) expression in the atherosclerotic intimas. The atherosclerotic lesions were histopathologically classified into types I through VI, as proposed by the American Heart Association Committee, and the numbers of intimal blood vessels and VEGF-positive cells were then morphometrically counted in sections that were immunohistochemically examined with anti-CD34 and human VEGF antibodies, respectively. The more the atherosclerotic lesion type advanced, the more often the lesion contained intimal blood vessels, which were expressed as percentages of the intimal section with intimal microvessels, viz, diffuse intimal thickening (DIT): 0% (0/111); type I, 31% (32/104); II, 42% (10/24); III, 66% (77/117); IV, 72% (48/67); V, 79% (70/89); and VI, 100% (13/13), P<0.0001. The number of VEGF-positive cells per intimal section was also positively correlated with the number of intimal blood vessels (P<0. 0001). The VEGF-positive cells were scattered in the fibrous caps as well as the shoulders and deeper areas of the plaques, and the double-immunostaining method revealed that the VEGF-positive cells were largely spindle-shaped, smooth muscle cells with some macrophage-derived foam cells. These findings thus suggest the possibility that the VEGF expressed by the smooth muscle cells and foamy macrophages in the atherosclerotic intimas can act as a local and endogenous regulator of endothelial cell functions, including intimal neovascularization, in atherosclerotic lesions of human coronary arteries.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9888875     DOI: 10.1161/01.atv.19.1.131

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  12 in total

1.  Delphinidin and cyanidin inhibit PDGF(AB)-induced VEGF release in vascular smooth muscle cells by preventing activation of p38 MAPK and JNK.

Authors:  M-H Oak; J E Bedoui; S V F Madeira; K Chalupsky; V B Schini-Kerth
Journal:  Br J Pharmacol       Date:  2006-08-21       Impact factor: 8.739

2.  Angiogenic activity of sera from extrinsic allergic alveolitis patients in relation to clinical, radiological, and functional pulmonary changes.

Authors:  Tadeusz M Zielonka; Urszula Demkow; Małgorzata Filewska; Beata Bialas; Katarzyna Zycinska; Elzbieta Radzikowska; Andrzej K Wardyn; Ewa Skopinska-Rozewska
Journal:  Lung       Date:  2010-07-06       Impact factor: 2.584

3.  Vascular endothelial growth factor and carotid intima-media thickness in patients with Behçet's disease.

Authors:  Mehmet Akif Oztürk; Selman Unverdi; Suna O Oktar; Neslihan Bukan; Ozlem Gülbahar; Kemal Ureten; Berna Göker; Seminur Haznedaroglu; Gülten Sungur; Tansu Ulukavak Ciftçi; A Mesut Onat
Journal:  Clin Rheumatol       Date:  2008-01-18       Impact factor: 2.980

4.  Does regular consumption of green tea influence expression of vascular endothelial growth factor and its receptor in aged rat erectile tissue? Possible implications for vasculogenic erectile dysfunction progression.

Authors:  D Neves; M Assunção; F Marques; J P Andrade; H Almeida
Journal:  Age (Dordr)       Date:  2008-04-18

5.  Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease.

Authors:  N A Chung; C Lydakis; F Belgore; F L Li-Saw-Hee; A D Blann; G Y H Lip
Journal:  Heart       Date:  2003-12       Impact factor: 5.994

6.  Imaging VEGF receptor expression to identify accelerated atherosclerosis.

Authors:  Yared Tekabe; Maria Kollaros; Adam Zerihoun; Geping Zhang; Marina V Backer; Joseph M Backer; Lynne L Johnson
Journal:  EJNMMI Res       Date:  2014-08-01       Impact factor: 3.138

7.  Effects of different doses of granulocyte colony-stimulating factor mobilization therapy on ischemic cardiomyopathy.

Authors:  Rongchong Huang; Haichen Lv; Kang Yao; Lei Ge; Zhishuai Ye; Huaiyu Ding; Yiqi Zhang; Hao Lu; Zheyong Huang; Shuning Zhang; Yunzeng Zou; Junbo Ge
Journal:  Sci Rep       Date:  2018-04-12       Impact factor: 4.379

Review 8.  The Role of CLEC-2 and Its Ligands in Thromboinflammation.

Authors:  Danyang Meng; Man Luo; Beibei Liu
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

9.  Development and Characterization of PLGA-Based Multistage Delivery System for Enhanced Payload Delivery to Targeted Vascular Endothelium.

Authors:  Jorge A Palma-Chavez; Kevin Fuentes; Brian E Applegate; Javier A Jo; Phapanin Charoenphol
Journal:  Macromol Biosci       Date:  2021-01-04       Impact factor: 5.859

Review 10.  Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models.

Authors:  Sara Gargiulo; Matteo Gramanzini; Marcello Mancini
Journal:  Int J Mol Sci       Date:  2016-09-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.